CAREDX, INC. financials

CDNA CIK 0001217234

Source: EDGAR filings · Built 2026-06-02T02:36:12Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EBITDA -15.76M 54.96M -188.98M -65.64M -20.93M -15.52M
Working Capital 167.28M 262.46M 235.64M 311.87M 356.06M 203.88M
Net Debt -39.23M -86.32M -47.98M -50.92M -327.13M -116.57M
Operating Margin -8.10% 12.21% -72.55% -24.00% -10.03% -11.72%
Net Margin -5.62% 15.74% -67.88% -23.81% -10.34% -9.74%
Return on Equity (ROE) -7.05% 13.89% -72.81% -17.78% -6.58% -6.74%
Return on Assets (ROA) -5.17% 10.70% -40.76% -14.11% -5.41% -5.08%
Current Ratio 2.86× 3.94× 4.02× 5.11× 5.61× 3.95×
Debt-to-Equity 0.09× 0.07× 0.13× 0.09× 0.05× 0.07×
Effective Tax Rate -1.29% 0.59% -0.07% -0.50% 4.44% 5.25%
Cash Conversion Ratio -1.97× 0.72× 0.10× 0.33× 0.63× -1.79×
Accruals Ratio -0.15× 0.03× -0.37× -0.09× -0.02× -0.14×
SBC % of Revenue 9.18% 19.89% 17.51% 14.47% 12.17% 12.18%

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 23.02×
EV / EBITDA 19.77×
P/S 2.53× 3.51× 2.20× 1.90× 8.12× 18.64×
P/B 3.16× 3.10× 2.37× 1.42× 5.17× 12.90×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 379.81M 333.79M 280.32M 321.79M 296.40M 192.19M
Research and Development Expense 71.43M 72.51M 82.42M 90.39M 76.53M 48.94M
Operating Expenses 410.59M 293.02M 483.69M 399.02M 326.12M 214.72M
Operating Income (Loss) -30.78M 40.77M -203.36M -77.23M -29.73M -22.53M
Income Tax Expense (Benefit) 271.00K 310.00K 141.00K 379.00K -1.43M -1.04M
Net Income (Loss) Attributable to Parent -21.35M 52.55M -190.28M -76.61M -30.66M -18.71M
Earnings Per Share, Basic $-0.40 $1.00 $-3.54 $-1.44 $-0.59 $-0.40
Weighted Average Number of Shares Outstanding, Basic 53.29M 52.77M 53.76M 53.32M 52.24M 46.48M
Earnings Per Share, Diluted $-0.40 $0.93 $-3.54 $-1.44 $-0.59 $-0.40
Weighted Average Number of Shares Outstanding, Diluted 53.29M 56.62M 53.76M 53.32M 52.24M 46.48M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 65.43M 114.69M 82.20M 89.92M 348.49M 134.67M
Assets, Current 257.13M 351.83M 313.71M 387.85M 433.36M 273.10M
Assets 413.23M 491.05M 466.83M 542.99M 566.62M 368.51M
Liabilities, Current 89.85M 89.37M 78.07M 75.97M 77.30M 69.22M
Long-term Debt, Excluding Current Maturities 0
Liabilities 110.13M 112.62M 205.50M 112.08M 100.75M 90.83M
Stockholders' Equity Attributable to Parent 303.10M 378.43M 261.33M 430.91M 465.88M 277.68M
Common Stock, Shares, Outstanding 50.92M 54.77M 51.50M 53.53M 52.92M 49.44M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 42.03M 38.05M -18.39M -25.24M -19.29M 33.43M
Net Cash Provided by (Used in) Investing Activities 2.16M -483.00K 40.45M -228.50M 47.71M -100.39M
Payments for Repurchase of Common Stock 87.77M 522.00K 27.54M 642.00K 0 0
Net Cash Provided by (Used in) Financing Activities -93.39M -5.61M -29.61M -4.54M 185.64M 163.15M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CDNA CIK 0001217234), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RVMD

Revolution Medicines, Inc.

BDL

FLANIGAN’S ENTERPRISES, INC.

IDN

Intellicheck, Inc.